Across the Princeton campus and beyond, groundbreaking biomedical advances are emerging from interdisciplinary partnerships ...

Micron Biomedical will be among the select honorees featured in the print edition of Fast Company on newsstands beginning March 31, 2026.

Biomedical engineers are innovators in a laboratory: bringing concepts and dreams of future technology and science fiction to life today to better people’s health and longevity. These faculty experts ...

The U.S. biomedical research enterprise—including discovery and translational research conducted by the federal government, pharmaceutical industry, health care, and public health—contributes ...

Healthcare has undergone dramatic revolutions over the last few decades with the introduction of technology. This is especially so with the collection of medical data using everyday objects such as ...

Out of every 10,000 to 15,000 new chemical compounds identified during drug discovery, just five will make it into human clinical trials. More than 92 percent of these drugs will fail in trials, ...

In January 2021, President Joe Biden issued executive order 13985 calling for the federal government to establish a comprehensive approach to advancing equity for all, including people with ...

LSU's Pennington Biomedical Research Center is hosting its fifth annual Senior Black American Health Fair on April 11th, ...

Tara Snyder ’17 (biomedical sciences) planned to go to medical school until her sophomore year at RIT. She had started volunteering on the pediatric floors at the Golisano Children’s Hospital in ...

Members of the Case Western Reserve University community are invited to an information session about the Master of Science in Biomedical & Health Informatics program Sunday, Feb. 26 from 7:30 to 8:30 ...

Pennington Biomedical Research Center is proud to open the campus for the 3rd annual Senior Black American Health Fair. Open to residents in the Greater Baton Rouge region and beyond, the health fair ...

To achieve the vision for an improved and more robust U.S. biomedical research enterprise laid out in Chapter 1, the federal government, academia, philanthropy, venture capital, and all other ...